Feasibility of Speedboat RS2 with bipolar radiofrequency energy for peroral endoscopic myotomy in patients with achalasia (with video)

Abstract

Background During peroral endoscopic myotomy (POEM), use of traditional instruments leads to an increase in overall time of procedure due to constant exchange of instruments. Speedboat-RS2 (Creo-Medical, UK) is a novel device which has shown promising results for endoscopic submucosal dissection of gastrointestinal lesions, but its feasibility, and safety for POEM is unexplored.

Methods Data from patients who had undergone POEM for achalasia cardia utilizing Speedboat-RS2 was reviewed.

Results Two patients with mean age of 46 years and mean symptom duration of 3 years were included. Both patients had type II achalasia diagnosed on esophageal manometry. One patient underwent anterior myotomy and the other posterior approach. Submucosal tunneling (~15 cm) was achieved in a mean of 20 minutes, myotomy (~ 9 cm) in 8 minutes and the entire procedure was completed in a mean of 30 minutes with 100 % technical success. Both patients were discharged the day after the procedure without any immediate adverse events. At 6 weeks, endoscopy was uneventful and the patients were asymptomatic.

Conclusions Early experience shows that Speedboat-RS2 is feasible for performing POEM with good safety profile. Submucosal tunneling was relatively quick and coagulation was effective. Long term studies with a larger patient cohort are warranted.

Publication History

Received: 28 January 2020

Accepted: 01 April 2020

Article published online:
21 July 2020

• References

• 1 Tang X, Ren Y, Wei Z. et al. Factors predicting the technical difficulty of peroral endoscopic myotomy for achalasia. Surg Endosc 2016; 30: 3774-3782
• 2 Tan Y, Li C, Yan J. et al. Difficult peroral endoscopic myotomy: definition and management strategies. Expert Rev Gastroenterol Hepatol 2019; 13: 933-942
• 3 Saunders BP, Tsiamoulos ZP, Bourikas L. et al. The “Speedboat”: a new multi-modality instrument for endoscopic resection in the gastrointestinal tract. Gastrointest Endosc 2013; 77: AB155
• 4 Tsiamoulos ZP, Sebastian J, Bagla N. et al. A new approach to endoscopic submucosal tunneling dissection: the “Speedboat-RS2” device. Endoscopy 2019; 51: E185-E186
• 5 Maydeo AP, Joshi NJ, Bhandari SP. Per oral endoscopic myotomy for a patient with achalasia cardia. J Assoc Physicians India 2012; 60: 66-68
• 6 Tsiamoulos ZP, Stasinos I, Oikonomakis A. et al. ATH-06. First clinical experience with speedboat-RS2, a new multimodality device for colonic submucosal dissection. Gut 2019; 68: A7-A8
• 7 Tsiamoulos ZP, Hancock CP, Bourikas L. et al. Sa1567. The “Speedboat-RS2”: a new multi-modality endoscopic device for gastric and oesophageal submucosal dissection and tunneling. Gastrointest Endosc 2014; 79: AB257-AB258
• 8 Maydeo A, Patil GK, Dalal A. Operative technical tricks and 12-month outcomes of diverticular peroral endoscopic myotomy (D-POEM) in patients with symptomatic esophageal diverticula. Endoscopy 2019; 51: 1136-1140
• 9 Inoue H, Maydeo A. Peroral endoscopic myotomy (POEM) opens the door of third-space endoscopy. Endoscopy 2019; 51: 1010-1012
• 10 Bipolar Electrosurgery Review. MDA evaluation 01022, March 2001. Available at (Accessed: 10 January 2020): http://www.cedar.wales.nhs.uk/sitesplus/documents/1091/01022%20Bipolar%20electrosurgery%20review%202001.pdf
• 11 Creo Medical’s Speedboat RS2. Available at (Accessed: 10 January 2020): https://investors.creomedical.com/what-we-do/our-products